Show simple item record

dc.contributor.authorStol, Daphne M
dc.contributor.authorOver, Eelco A B
dc.contributor.authorBadenbroek, Ilse F
dc.contributor.authorHollander, Monika
dc.contributor.authorNielen, Mark M J
dc.contributor.authorKraaijenhagen, Roderik A
dc.contributor.authorSchellevis, François G
dc.contributor.authorde Wit, Niek J
dc.contributor.authorde Wit, G Ardine
dc.date.accessioned2021-03-16T14:49:21Z
dc.date.available2021-03-16T14:49:21Z
dc.date.issued2021-03-11
dc.identifier.pmid33691699
dc.identifier.doi10.1186/s12916-021-01933-6
dc.identifier.urihttp://hdl.handle.net/10029/624781
dc.language.isoenen_US
dc.subjectCardiometabolic diseasesen_US
dc.subjectCardiovascular diseaseen_US
dc.subjectCost-effectiveness analysisen_US
dc.subjectDiabetes type 2en_US
dc.subjectEconomic evaluationen_US
dc.subjectModelling studyen_US
dc.subjectPreventionen_US
dc.subjectPrimary careen_US
dc.titleCost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care.en_US
dc.typeArticleen_US
dc.identifier.eissn1741-7015
dc.identifier.journalBMC medicineen_US
dc.source.journaltitleBMC medicine
dc.source.volume19
dc.source.issue1
dc.source.beginpage57
dc.source.endpage
dc.source.countryNetherlands
dc.source.countryEngland


This item appears in the following Collection(s)

Show simple item record